315 related articles for article (PubMed ID: 21128826)
1. Antifungal activity of the honeybee products against Candida spp. and Trichosporon spp.
Koç AN; Silici S; Kasap F; Hörmet-Oz HT; Mavus-Buldu H; Ercal BD
J Med Food; 2011; 14(1-2):128-34. PubMed ID: 21128826
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of Turkish honey against Candida spp. and Trichosporon spp: an in vitro evaluation.
Koc AN; Silici S; Ercal BD; Kasap F; Hörmet-Oz HT; Mavus-Buldu H
Med Mycol; 2009 Nov; 47(7):707-12. PubMed ID: 19888803
[TBL] [Abstract][Full Text] [Related]
3. Antifungal Activity of Propolis Against Yeasts Isolated From Blood Culture: In Vitro Evaluation.
Mutlu Sariguzel F; Berk E; Koc AN; Sav H; Demir G
J Clin Lab Anal; 2016 Sep; 30(5):513-6. PubMed ID: 26791093
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activities of propolis collected by different races of honeybees against yeasts isolated from patients with superficial mycoses.
Silici S; Koç NA; Ayangil D; Cankaya S
J Pharmacol Sci; 2005 Sep; 99(1):39-44. PubMed ID: 16141640
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis.
Siqueira AB; Rodriguez LR; Santos RK; Marinho RR; Abreu S; Peixoto RF; Gurgel BC
Braz Oral Res; 2015; 29():. PubMed ID: 26154370
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.
Sokolonski AR; Fonseca MS; Machado BAS; Deegan KR; Araújo RPC; Umsza-Guez MA; Meyer R; Portela RW
BMC Complement Med Ther; 2021 Nov; 21(1):286. PubMed ID: 34814913
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of propolis on different species of Candida.
Ota C; Unterkircher C; Fantinato V; Shimizu MT
Mycoses; 2001 Nov; 44(9-10):375-8. PubMed ID: 11766101
[TBL] [Abstract][Full Text] [Related]
9. Yeasts as important agents of onychomycosis: in vitro activity of propolis against yeasts isolated from patients with nail infection.
Khosravi AR; Shokri H; Nikaein D; Mansouri P; Erfanmanesh A; Chalangari R; Katalin M
J Altern Complement Med; 2013 Jan; 19(1):57-62. PubMed ID: 22954465
[TBL] [Abstract][Full Text] [Related]
10. Comparative effect of propolis of honey bee and some herbal extracts on Candida albicans.
Gavanji S; Larki B
Chin J Integr Med; 2017 Mar; 23(3):201-207. PubMed ID: 26149083
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Pfaller MA; Castanheira M; Messer SA; Jones RN
Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of propolis extract against yeasts isolated from vaginal exudates.
Dalben-Dota KF; Faria MG; Bruschi ML; Pelloso SM; Lopes-Consolaro ME; Svidzinski TI
J Altern Complement Med; 2010 Mar; 16(3):285-90. PubMed ID: 20192913
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Nov; 43(11):5425-7. PubMed ID: 16272464
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a breakpoint test for determination of fluconazole susceptibility of yeasts].
Fegeler W
Mycoses; 1997; 40 Suppl 1():47-52. PubMed ID: 9417513
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
17. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
[TBL] [Abstract][Full Text] [Related]
18. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
20. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
